Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Atai Life Sciences N.v. (ATAI) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Atai Life Sciences N.v.. Table 2 shows the detailed insider transactions. This company's CIK number is 1840904.
Total stock buying since 2021: $47,423,377.
Total stock sales since 2021: $767,510.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 10,475,799 | $21,519,999 | 182,250 | $246,036 | 427,500 | $0 |
| 2024 | 0 | $0 | 276,154 | $521,474 | 725,000 | $0 |
| 2023 | 1,344,297 | $1,785,053 | 0 | $0 | 0 | $0 |
| 2022 | 546,188 | $2,680,880 | 0 | $0 | 0 | $0 |
| 2021 | 1,429,163 | $21,437,445 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 8,675,799 | $18,999,999 | 0 | $0 | 0 | $0 |
| 2025-03 | 1,800,000 | $2,520,000 | 182,250 | $246,036 | 427,500 | $0 |
| 2024-05 | 0 | $0 | 151,303 | $290,501 | 0 | $0 |
| 2024-04 | 0 | $0 | 124,851 | $230,973 | 0 | $0 |
| 2024-03 | 0 | $0 | 0 | $0 | 725,000 | $0 |
| 2023-11 | 20,000 | $23,120 | 0 | $0 | 0 | $0 |
| 2023-09 | 40,000 | $57,960 | 0 | $0 | 0 | $0 |
| 2023-03 | 1,284,297 | $1,703,973 | 0 | $0 | 0 | $0 |
| 2022-04 | 546,188 | $2,680,880 | 0 | $0 | 0 | $0 |
| 2021-06 | 1,429,163 | $21,437,445 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-14 | Angermayer Christian | Buy | 8,675,799 | 2.19 | 18,999,999 |
| 2025-03-24 | Angermayer Christian | Buy | 1,800,000 | 1.40 | 2,520,000 |
| 2025-03-21 | Craig Kevin James (Chief Medical Officer) | Sale | 11,563 | 1.35 | 15,610 |
| 2025-03-21 | Short Glenn Frank (Chief Scientific Officer) | Sale | 13,161 | 1.35 | 17,767 |
| 2025-03-21 | Johnson Anne Nagengast (Chief Financial Officer) | Sale | 33,545 | 1.35 | 45,285 |
| 2025-03-21 | Kirpekar Sahil (Chief Business Officer) | Sale | 48,563 | 1.35 | 65,560 |
| 2025-03-21 | Rao Srinivas (See Remarks) | Sale | 75,418 | 1.35 | 101,814 |
| 2025-03-14 | Craig Kevin James (Chief Medical Officer) | Option Ex | 20,000 | .00 | 0 |
| 2025-03-14 | Short Glenn Frank (Chief Scientific Officer) | Option Ex | 32,500 | .00 | 0 |
| 2025-03-14 | Johnson Anne Nagengast (Chief Financial Officer) | Option Ex | 100,000 | .00 | 0 |
| 2025-03-14 | Kirpekar Sahil (Chief Business Officer) | Option Ex | 100,000 | .00 | 0 |
| 2025-03-14 | Rao Srinivas (See Remarks) | Option Ex | 175,000 | .00 | 0 |
| 2024-05-16 | Brand Florian (See Remarks) | Sale | 151,303 | 1.92 | 290,501 |
| 2024-04-02 | Johnson Anne Nagengast (Chief Financial Officer) | Sale | 27,410 | 1.85 | 50,708 |
| 2024-04-02 | Kirpekar Sahil (Chief Business Officer) | Sale | 35,801 | 1.85 | 66,231 |
| 2024-04-02 | Rao Srinivas (See Remarks) | Sale | 61,640 | 1.85 | 114,034 |
| 2024-03-14 | Johnson Anne Nagengast (Chief Financial Officer) | Option Ex | 100,000 | .00 | 0 |
| 2024-03-14 | Kirpekar Sahil (Chief Business Officer) | Option Ex | 100,000 | .00 | 0 |
| 2024-03-14 | Rao Srinivas (See Remarks) | Option Ex | 175,000 | .00 | 0 |
| 2024-03-14 | Brand Florian (See Remarks) | Option Ex | 350,000 | .00 | 0 |
| 2023-11-16 | Brand Florian (See Remarks) | Buy | 20,000 | 1.16 | 23,120 |
| 2023-09-13 | Brand Florian (See Remarks) | Buy | 40,000 | 1.45 | 57,960 |
| 2023-03-29 | Brand Florian (See Remarks) | Buy | 70,000 | 1.48 | 103,530 |
| 2023-03-29 | Angermayer Christian (10% Owner) | Buy | 1,214,297 | 1.32 | 1,600,443 |
| 2022-04-29 | Angermayer Christian (10% Owner) | Buy | 21,900 | 4.47 | 97,805 |
| 2022-04-28 | Angermayer Christian (10% Owner) | Buy | 34,700 | 4.46 | 154,692 |
| 2022-04-25 | Angermayer Christian (10% Owner) | Buy | 8,961 | 4.78 | 42,842 |
| 2022-04-22 | Angermayer Christian (10% Owner) | Buy | 52,820 | 4.83 | 254,962 |
| 2022-04-21 | Angermayer Christian (10% Owner) | Buy | 68,688 | 4.95 | 340,074 |
| 2022-04-20 | Angermayer Christian (10% Owner) | Buy | 67,703 | 5.09 | 344,540 |
| 2022-04-19 | Angermayer Christian (10% Owner) | Buy | 65,315 | 5.12 | 334,739 |
| 2022-04-18 | Angermayer Christian (10% Owner) | Buy | 54,322 | 5.11 | 277,639 |
| 2022-04-14 | Angermayer Christian (10% Owner) | Buy | 4,967 | 5.19 | 25,778 |
| 2022-04-12 | Angermayer Christian (10% Owner) | Buy | 55,197 | 4.88 | 269,582 |
| 2022-04-11 | Angermayer Christian (10% Owner) | Buy | 53,926 | 4.83 | 260,570 |
| 2022-04-08 | Angermayer Christian (10% Owner) | Buy | 57,689 | 4.81 | 277,657 |
| 2021-06-22 | Rao Srinivas (See Remarks) | Buy | 3,500 | 15.00 | 52,500 |
| 2021-06-22 | Brand Florian (See Remarks) | Buy | 2,333 | 15.00 | 34,995 |
| 2021-06-22 | De Rosnay Alexis (Director) | Buy | 4,666 | 15.00 | 69,990 |
| 2021-06-22 | Presight Ii, Lp (10% Owner) | Buy | 700,000 | 15.00 | 10,500,000 |
| 2021-06-22 | Angermayer Christian (Director) | Buy | 700,000 | 15.00 | 10,500,000 |
| 2021-06-22 | Auerbach Michael (Director) | Buy | 4,666 | 15.00 | 69,990 |
| 2021-06-22 | Smiley Andrea Heslin (Director) | Buy | 4,666 | 15.00 | 69,990 |
| 2021-06-22 | Kalali Amir H (Director) | Buy | 4,666 | 15.00 | 69,990 |
| 2021-06-22 | Weaver Gregory L (Chief Financial Officer) | Buy | 4,666 | 15.00 | 69,990 |
Insider trading activities including stock purchases, stock sales, and option exercises of ATAI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Atai Life Sciences N.v. (symbol ATAI, CIK number 1840904) see the Securities and Exchange Commission (SEC) website.